Search

Your search keyword '"Cancer patients -- Drug therapy"' showing total 4,797 results

Search Constraints

Start Over You searched for: Descriptor "Cancer patients -- Drug therapy" Remove constraint Descriptor: "Cancer patients -- Drug therapy"
4,797 results on '"Cancer patients -- Drug therapy"'

Search Results

301. Recent Studies from Peking University Cancer Hospital and Institute Add New Data to Gastric Cancer (Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: ...)

303. Research Reports from Ghent Provide New Insights into Biomarkers (Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors)

304. Heidelberg University Hospital Reports Findings in Cancer [Patient Enrollment per Month (Accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs]

305. Studies from Kyoto Prefectural University of Medicine Have Provided New Data on Ovarian Cancer (Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian Cancer)

306. Reports from First Affiliated Hospital of Harbin Medical University Describe Recent Advances in Colon Cancer (Compliance Status and Influencing Factors of Oral Anti-tumor Targeted Drugs inElderly Patients with Colon Cancer after Discharge)

307. Researchers from Tongji University Publish Findings in Thyroid Cancer (Early and long-term responses of intestinal microbiota and metabolites to 131I treatment in differentiated thyroid cancer patients)

308. Researchers from University of Catania Describe Findings in Type 2 Diabetes (Body Mass Index Is Related To Short-term Retinal Worsening In Type 2 Diabetes Mellitus Patients Treated With Anticancer Drugs)

309. Chung Shan Medical University Hospital Researcher Reports Recent Findings in Personalized Medicine (Longitudinal Risk Analysis of Second Primary Cancer after Curative Treatment in Patients with Rectal Cancer)

310. Researcher at University of North Carolina Chapel Hill Releases New Study Findings on Esophageal Cancer (The Role of Immunotherapy in the Management of Esophageal Cancer in Patients Treated with Neoadjuvant Chemoradiation: An Analysis of the ...)

311. Researchers at Howard University Release New Data on Bladder Cancer (Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric ...)

312. New Findings from Xinjiang Medical University Describe Advances in Oral Cancer (Effect of Prophylactic Placement of Percutaneous Endoscopic Gastrostomy On the Surgical Prognosis In Patients With Oral Cancer: a Pilot Study)

313. Investigators at Baylor University College of Medicine Report Findings in Blood Cancer (Time To Optimize Vaccination Strategies In Blood Cancer Patients)

314. Researchers from University of Ioannina School of Medicine Detail Findings in Type 2 Diabetes (Expression of ten-eleven translocation 2 and glutathione-S-transferase pi in colorectal cancer patients with and without type 2 diabetes mellitus)

315. University of Aveiro Researchers Advance Knowledge in Cancer (Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors)

317. Banner University Medical Center Researchers Target Lung Cancer (Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis)

318. Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

319. Studies from Georges Pompidou European Hospital Further Understanding of Venous Thromboembolism (Translation Into French and Republication Of: 'home Treatment for Patients With Cancer-associated Venous Thromboembolism.')

320. Research from Monash University Yields New Findings on Atherosclerosis (Cardiovascular Risk in Cancer Patients Treated with Immune Checkpoint Inhibitors: Challenges and Future Directions)

321. Research from Cross Cancer Institute Has Provided New Data on Gastric Cancer [A phase 2 study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastric cancer: Efficacy and safety analysis (BOLD-100-001)]

322. New Data from Chang Gung Memorial Hospital Illuminate Findings in Esophageal Cancer (Can Chinese Herbal Medicine Offer Feasible Solutions for Newly Diagnosed Esophageal Cancer Patients With Malnutrition? a Multi-institutional Real-world Study)

323. Shiga General Hospital Reports Findings in Lung Cancer (Unifying gamma passing rates in patient-specific QA for VMAT lung cancer treatment based on data assimilation)

324. Data from University of Montreal Provide New Insights into Prostate Cancer (Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Secondary analysis of the SPARTAN trial)

325. Findings from University of Pisa Update Understanding of Colon Cancer (Treatment of Patients With Brafv600e-mutated Metastatic Colorectal Cancer After Progression To Encorafenib and Cetuximab: Data From a Real-world Nationwide Data

326. Data on COVID-19 Described by a Researcher at Luigi Sacco Hospital (Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center ...)

327. Study Data from University of Queensland Provide New Insights into Head and Neck Cancer (Improving Patient and Carer Access To Information and Support Through Head and Neck Cancer Treatment and Survivorship Using Experience-based Co-design)

328. First Affiliated Hospital of Zhengzhou University Researchers Have Published New Study Findings on Gastric Cancer (Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients)

329. New Findings in Cancer Described from University of La Laguna (Instruments for Evaluating the Nutritional Status of Cancer Patients Undergoing Antineoplastic Treatment: A Scoping Review)

330. Zephyr AI Presents the Development of a Novel AI-Enabled Composite Biomarker Effective in Predicting Sensitivity to PARP Inhibition in Late-line Cancer Patients

331. Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines

332. Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner

333. Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner

334. Peru : Alberto Sabogal Hospital guarantees delivery of medicines to cancer patients

335. NEW JERSEY MARINE BECOMES PROCURE'S 7,000TH PATIENT TO COMPLETE CANCER TREATMENT

336. TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

337. NEW JERSEY MARINE BECOMES PROCURE'S 7,000TH PATIENT TO COMPLETE CANCER TREATMENT

338. New heated drug baths provide hope for patients with stomach cancer

339. United States : NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients

340. Novartis radioligand therapy Lutathera(r) FDA approved for pediatric patients

341. US FDA accepts for priority review GSK's application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer

342. Novartis radioligand therapy Lutathera(r) FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors

343. NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients

344. NIH RESEARCHERS DEVELOP AI TOOL WITH POTENTIAL TO MORE PRECISELY MATCH CANCER DRUGS TO PATIENTS

345. NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients

346. BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients

347. Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol

348. Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

349. Immunotherapy Before Surgery Might Boost Pancreatic Cancer Survival

Catalog

Books, media, physical & digital resources